$0.460000
0.036.98%
At Close: -
$0.455000
-0.0050-1.09%
After Hours: Sep 20, 7:59 PM EDT
15 minutes delayed
Unicycive Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Unicycive Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.15 | $-0.19 | 21.1 % |
Mar 2024 | 2024-05-13 | $-0.61 | $-0.15 | -306.7 % |
Dec 2023 | 2024-03-28 | $-0.22 | $-0.17 | -29.4 % |
Sep 2023 | 2023-11-14 | $-0.37 | $-0.12 | -208.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-05-16 | $0 | $370.00K | -100.0 % |
Unicycive Therapeutics (UNCY) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.15, which beat the estimate of $-0.19.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.